Literature DB >> 23330953

Molecular control of steady-state dendritic cell maturation and immune homeostasis.

Gianna Elena Hammer1, Averil Ma.   

Abstract

Dendritic cells (DCs) are specialized sentinels responsible for coordinating adaptive immunity. This function is dependent upon coupled sensitivity to environmental signs of inflammation and infection to cellular maturation-the programmed alteration of DC phenotype and function to enhance immune cell activation. Although DCs are thus well equipped to respond to pathogens, maturation triggers are not unique to infection. Given that immune cells are exquisitely sensitive to the biological functions of DCs, we now appreciate that multiple layers of suppression are required to restrict the environmental sensitivity, cellular maturation, and even life span of DCs to prevent aberrant immune activation during the steady state. At the same time, steady-state DCs are not quiescent but rather perform key functions that support homeostasis of numerous cell types. Here we review these functions and molecular mechanisms of suppression that control steady-state DC maturation. Corruption of these steady-state operatives has diverse immunological consequences and pinpoints DCs as potent drivers of autoimmune and inflammatory disease.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23330953      PMCID: PMC4091962          DOI: 10.1146/annurev-immunol-020711-074929

Source DB:  PubMed          Journal:  Annu Rev Immunol        ISSN: 0732-0582            Impact factor:   28.527


  305 in total

1.  Macrophage- and dendritic-cell-derived interleukin-15 receptor alpha supports homeostasis of distinct CD8+ T cell subsets.

Authors:  Erwan Mortier; Rommel Advincula; Leesun Kim; Stephen Chmura; Julio Barrera; Boris Reizis; Barbara A Malynn; Averil Ma
Journal:  Immunity       Date:  2009-11-12       Impact factor: 31.745

2.  Inhibition of NF-kappaB signaling by A20 through disruption of ubiquitin enzyme complexes.

Authors:  Noula Shembade; Averil Ma; Edward W Harhaj
Journal:  Science       Date:  2010-02-26       Impact factor: 47.728

3.  C-type lectin SIGN-R1 has a role in experimental colitis and responsiveness to lipopolysaccharide.

Authors:  Sean P Saunders; Jillian L Barlow; Caitriona M Walsh; Agustin Bellsoi; Philip Smith; Andrew N J McKenzie; Padraic G Fallon
Journal:  J Immunol       Date:  2010-02-03       Impact factor: 5.422

4.  Dendritic cell (DC)-specific targeting reveals Stat3 as a negative regulator of DC function.

Authors:  Jessica A Melillo; Li Song; Govind Bhagat; Ana Belen Blazquez; Courtney R Plumlee; Carolyn Lee; Cecilia Berin; Boris Reizis; Christian Schindler
Journal:  J Immunol       Date:  2010-02-01       Impact factor: 5.422

Review 5.  Toll-like receptor signaling in cell proliferation and survival.

Authors:  Xinyan Li; Song Jiang; Richard I Tapping
Journal:  Cytokine       Date:  2009-09-22       Impact factor: 3.861

6.  NOD2 stimulation induces autophagy in dendritic cells influencing bacterial handling and antigen presentation.

Authors:  Rachel Cooney; John Baker; Oliver Brain; Benedicte Danis; Tica Pichulik; Philip Allan; David J P Ferguson; Barry J Campbell; Derek Jewell; Alison Simmons
Journal:  Nat Med       Date:  2009-12-06       Impact factor: 53.440

7.  Discrete domains of MARCH1 mediate its localization, functional interactions, and posttranscriptional control of expression.

Authors:  Maurice Jabbour; Erin M Campbell; Hanna Fares; Lonnie Lybarger
Journal:  J Immunol       Date:  2009-10-30       Impact factor: 5.422

8.  Human suppressor of cytokine signaling 1 controls immunostimulatory activity of monocyte-derived dendritic cells.

Authors:  Bangxing Hong; Wenhong Ren; Xiao-Tong Song; Kevin Evel-Kabler; Si-Yi Chen; Xue F Huang
Journal:  Cancer Res       Date:  2009-09-29       Impact factor: 12.701

9.  Cutting edge: requirement of MARCH-I-mediated MHC II ubiquitination for the maintenance of conventional dendritic cells.

Authors:  Mari Ohmura-Hoshino; Yohei Matsuki; Mari Mito-Yoshida; Eiji Goto; Masami Aoki-Kawasumi; Manabu Nakayama; Osamu Ohara; Satoshi Ishido
Journal:  J Immunol       Date:  2009-11-16       Impact factor: 5.422

10.  Intestinal CD103+, but not CX3CR1+, antigen sampling cells migrate in lymph and serve classical dendritic cell functions.

Authors:  Olga Schulz; Elin Jaensson; Emma K Persson; Xiaosun Liu; Tim Worbs; William W Agace; Oliver Pabst
Journal:  J Exp Med       Date:  2009-12-14       Impact factor: 14.307

View more
  61 in total

Review 1.  Microbial activation of gut dendritic cells and the control of mucosal immunity.

Authors:  Jennifer L Owen; Mansour Mohamadzadeh
Journal:  J Interferon Cytokine Res       Date:  2013-08-20       Impact factor: 2.607

Review 2.  Collaboration of Toll-like and RIG-I-like receptors in human dendritic cells: tRIGgering antiviral innate immune responses.

Authors:  Attila Szabo; Eva Rajnavolgyi
Journal:  Am J Clin Exp Immunol       Date:  2013-10-16

3.  Alterations in Intestinal Microbiota Correlate With Susceptibility to Type 1 Diabetes.

Authors:  Aimon K Alkanani; Naoko Hara; Peter A Gottlieb; Diana Ir; Charles E Robertson; Brandie D Wagner; Daniel N Frank; Danny Zipris
Journal:  Diabetes       Date:  2015-06-11       Impact factor: 9.461

Review 4.  Targeting of tolerogenic dendritic cells towards heat-shock proteins: a novel therapeutic strategy for autoimmune diseases?

Authors:  Manon A A Jansen; Rachel Spiering; Femke Broere; Jacob M van Laar; John D Isaacs; Willem van Eden; Catharien M U Hilkens
Journal:  Immunology       Date:  2017-09-18       Impact factor: 7.397

5.  High-throughput sequencing reveals key genes and immune homeostatic pathways activated in myeloid dendritic cells by Porphyromonas gingivalis 381 and its fimbrial mutants.

Authors:  P Arjunan; A El-Awady; R O Dannebaum; G Kunde-Ramamoorthy; C W Cutler
Journal:  Mol Oral Microbiol       Date:  2015-10-16       Impact factor: 3.563

Review 6.  The origin of DCs and capacity for immunologic tolerance in central and peripheral tissues.

Authors:  K Sanjana P Devi; Niroshana Anandasabapathy
Journal:  Semin Immunopathol       Date:  2016-11-25       Impact factor: 9.623

Review 7.  Trial watch: Dendritic cell-based anticancer therapy.

Authors:  Norma Bloy; Jonathan Pol; Fernando Aranda; Alexander Eggermont; Isabelle Cremer; Wolf Hervé Fridman; Jitka Fučíková; Jérôme Galon; Eric Tartour; Radek Spisek; Madhav V Dhodapkar; Laurence Zitvogel; Guido Kroemer; Lorenzo Galluzzi
Journal:  Oncoimmunology       Date:  2014-12-21       Impact factor: 8.110

8.  Induction of antitumor cytotoxic lymphocytes using engineered human primary blood dendritic cells.

Authors:  Long Wu; Huan Zhang; Yixing Jiang; Robert C Gallo; Hua Cheng
Journal:  Proc Natl Acad Sci U S A       Date:  2018-04-19       Impact factor: 11.205

9.  Cd47-Sirpα interaction and IL-10 constrain inflammation-induced macrophage phagocytosis of healthy self-cells.

Authors:  Zhen Bian; Lei Shi; Ya-Lan Guo; Zhiyuan Lv; Cong Tang; Shuo Niu; Alexandra Tremblay; Mahathi Venkataramani; Courtney Culpepper; Limin Li; Zhen Zhou; Ahmed Mansour; Yongliang Zhang; Andrew Gewirtz; Koby Kidder; Ke Zen; Yuan Liu
Journal:  Proc Natl Acad Sci U S A       Date:  2016-08-30       Impact factor: 11.205

10.  Inhibition of SIRPα in dendritic cells potentiates potent antitumor immunity.

Authors:  Qiong Liu; Wen Wen; Liang Tang; Chen-Jie Qin; Yan Lin; Hui-Lu Zhang; Han Wu; Charles Ashton; Hong-Ping Wu; Jin Ding; Wei Dong; Le-Xing Yu; Wen Yang; Dan-Dan Huang; Meng-Chao Wu; Hong-Yang Wang; He-Xin Yan
Journal:  Oncoimmunology       Date:  2016-08-23       Impact factor: 8.110

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.